Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × Immunohistochemistry × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Rectal Neoplasms 2 Colorectal Neoplasms 2 Tongue Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Ependymoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1 Biliary Tract Neoplasms 1

Interventions

ruxolitinib 19 Cyclophosphamide 11 Whole-Body Irradiation 9 Tacrolimus 8 fludarabine phosphate 7 fludarabine 7 Stem Cell Transplantation 7 Mycophenolic Acid 7 Specimen Handling 6 Peripheral Blood Stem Cell Transplantation 6 Azacitidine 5 Melphalan 4 Busulfan 4 Biopsy 4 fedratinib 3 Sirolimus 3 Methotrexate 3 Injections 3 venetoclax 2 selinexor 2 navitoclax 2 luspatercept 2 letermovir 2 itacitinib 2 bomedemstat 2 INCB057643 2 INCB039110 2 Hematopoietic Stem Cell Transplantation 2 Decitabine 2 Cyclosporine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡